RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Neuro, It would give them a lot more flexibility having the authorized limit raised ahead of time. Ideally they should also have a new shelf registration in place.

Let's say the SA results are good, and the pps temporarily zooms up to .75 or $1. Varney needs the ability to do a quick financing at these higher levels to keep the doors open and allow some breathing room for partner/licensing negotiations.

I was surprised they didn't seek to raise the authorized share limit at the SHM in June. It requires a vote by shareholders. They should also set up / renew a shelf registration of the type they had previously. No one likes to have to raise the authorized limit again, but as CEO you have be proactive and just do it.